Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
   Gilead's Remdesivir Shows Consistent Efficacy In Patients With Comorbidities With Higher Risk for Severe COVID-19
   
  December 23, 2021
  Tickers 
   GILD
  
  
  From Benzinga
 
   Mereo BioPharma's Alvelestat Shows Improvement In COVID-19 Severity
   
  December 22, 2021
  Tickers 
   MREO
  
  
  From Benzinga
 
   FDA To Possibly Authorize Pfizer, Merck COVID-19 Antiviral Pills This Week: Bloomberg
   
  
  
  December 22, 2021
  From Benzinga
 
   UK Calls For Additional Doses Of COVID-19 Antivirals From Merck, Pfizer
   
  
  
  December 22, 2021
  From Benzinga
 
   BiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody
   
  December 22, 2021
  Tickers 
   BVXV
  
  
  From Benzinga
 
   Novavax Initiates Phase 3 COVID-19 Vaccine Booster Study
   
  December 22, 2021
  Tickers 
   NVAX
  
  
  From Benzinga
 
   European Commission Expands Use Of Remdesivir In COVID-19 Patients Not On Supplemental Oxygen
   
  December 21, 2021
  Tickers 
   GILD
  
  
  From Benzinga
 
   Aridis Stock Rallies After Positive Preclinical Data For COVID-19 Antibody Against Omicron
   
  December 21, 2021
  Tickers 
   ARDS
  
  
  From Benzinga
 
   Novavax's COVID-19 Vaccine Scores Conditional Approval In Europe
   
  December 20, 2021
  Tickers 
   NVAX
  
  
  From Benzinga
 
   Moderna's Authorized COVID-19 Booster Increases Omicron Neutralizing Antibody Levels 37-Fold
   
  December 20, 2021
  Tickers 
   MRNA
  
  
  From Benzinga
 
   Pfizer Plans To Evaluate Third Shot For Its COVID-19 Vaccine In Kids Below 5 Years
   
  
  
  December 17, 2021
  From Benzinga
 From Benzinga
 
   CDC Backs mRNA COVID-19 Vaccines Over Johnson & Johnson's, Citing Higher Rates Of Clotting Cases: Report
   
  
  
  December 17, 2021
  From Benzinga
 From Benzinga
 
   Johnson & Johnson's, Sputnik, Sinopharm COVID-19 Vaccines Show Weakness Against Omicron Variant: Study
   
  
  
  December 17, 2021
  From Benzinga
 
   Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15
   
  
  
  December 17, 2021
  From Benzinga
 
   AstraZeneca's COVID-19 Antibody Effective Against Omicron Variant
   
  
  
  December 16, 2021
  From Benzinga
 
   EMA Offers Early Access To Pfizer's COVID-19 Pill Paxlovid
   
  December 16, 2021
  Tickers 
   PFE
  
  
  From Benzinga
 From Benzinga
 
   Valneva's COVID-19 Vaccine Booster Works As A Follow-Up To Its Own Shot
   
  December 16, 2021
  Tickers 
   VALN
  
  
  From Benzinga
 
   FDA Lab Testing Confirms SAB Biotherapeutics' COVID-19 Antibody Neutralizes Omicron Variant
   
  December 16, 2021
  Tickers 
   SABS
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.